Pesticide Exposure During Pregnancy Linked to Brain Problems: Study
New research suggests that there could be a link between child brain anomalies and exposure during pregnancy to a common form of pesticide, which has been banned in homes but is still used on farms and golf courses across the United States.
According to a study published in the April 30 edition of Proceedings of the National Academy of Sciences, U.S. researchers examined the risk of prenatal exposure to a class of organophosphate insecticides known as chlorpyrifos (CPF), finding a correlation between exposure to high levels of the chemical in the womb and abnormal brain growths.
Researchers looked at 40 children, 20 of whom were born to mothers who had high exposure to CPF and 20 who had low levels of exposure. The levels of exposure were measured by testing umbilical cord blood.
Did You Know? Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.Learn More
Children who had high levels of CPF exposure were found to be more likely to have enlarged sections of the right hemisphere of the brain. The enlarged sections of the brain could be harmful to developing children and may be tied to some gender abnormalities.
The high CPF exposure children also had brain regions that failed to show expected sex differences in certain parts of the brain and sometimes had brain features that were typically found in the opposite gender, according to the findings.
CPF is not used in homes, but it is used to spray golf courses, Christmas tree farms and is even used to keep insects from nesting on highway dividers. It is also heavily used on corn crops and fruit, which is the most likely vector of exposure to pregnant mothers.
While the study found no causal link between the abnormal brain growths and pesticide exposure, they determined that there was a “significant association” between the pesticide and structural changes in the developing human brain.
"*" indicates required fields
More Top Stories
The President has signed the Camp Lejeune Justice Act into law as part of a larger package of veterans toxic chemical exposure health care benefits, which will allow those exposed to water contamination while living or serving on the base to file lawsuits against the federal government.
Ahead of the first Zantac lawsuit trials, slated to begin next year, investors sold off Sanofi, GlaxoSmithKline and Pfizer stocks, anticipating massive court losses and costs.
A federal judge has issued a pretrial scheduling order setting the first Nexium kidney damage lawsuit to go before a jury in November.